IMMUNOTHERAPY AND CANCER
According to the National Cancer Institute, immunotherapy is defined as a treatment to boost or restore the ability of the immune system to fight cancer, infections, and other diseases.
There Are 2 Types of Immunotherapy for Cancer
ACTIVE IMMUNOTHERAPY
Active immunotherapy engages the immune system and is typically very durable. An excellent example is the protocol we developed known as Multiphasic Intravenous Antigen Presentation Immunomodulation.
PASSIVE IMMUNOTHERAPY
Passive immunotherapy enhances pre-existing immune response and has a short life. Examples include monoclonal antibodies and cytokines.
Immunotherapy is Adaptable (2:42)
Immunotherapy – The basics (2:32)
Immunotherapy is Proven Effective in Cancer
Immunotherapies, such as monoclonal antibodies, checkpoint inhibitors, cytokines, and therapeutic vaccines, have been approved by the FDA to treat certain cancers.2
FDA-APPROVED IMMUNOTHERAPIES*,2-6
| Class | Approvals |
|---|---|
| Monoclonal antibodies | 1997, 1998, 2000, 2001, 2002, 2003, 2004, 2006, 2009 |
| Checkpoint inhibitor | 2011 |
| Cytokines | 1986, 1992, 1995, 1998 |
| Therapeutic vaccine | 2010 |
*Not inclusive of all immunotherapy classes.
Immunotherapy is Tumor-Specific (2:03)
Immunotherapy Cancer a guide for patients (3:26)
Immunotherapy Empowers a Durable Immune Response (2:19)
Cytotoxic cells killing cervical cancer cells (0:32)
A killer T-cell Destroying Cancer (1:10)
Natural killer T cell recognizing cancer (0:54)
Immunotherapy Commercial (0:57)
Immunotherapy Now Promoted By Johns Hopkins (3:59)
Various NK cells killing cancer cells (1:29)
Immunotherapy is now promoted by MSKCC (1:19)
How the immune system sees and destroys tumors (28:35)
T Cell Cancer Assassin (1:58)
Natural Killer Cell Attacking a Tumor Cell (0:47)
Immunotherapy is now promoted by UCLA (3:12)
Immunotherapy Awareness Month (0:46)
NK cells killing cancer cells
(0:20)
Immunology of the Gut Mucosa (5:56)
Our Immune System Inflammatory Response (4:45)
Immunotherapy Animated Explanation (3:02)
Natural Killer Cell 01
(0:25)
Terminator NK Cells (0:51)
REFERENCES
- Rescigno M, Curigliano G, et al. Biochim Biophys Acta. 2007;1776(1):108-123.
- Mellman I, Dranoff G, et al. Nature. 2011;480(7378):480-489.
- Kirkwood JM, Ferrone S, et al. CA Cancer J Clin. 2012;62(5):309-335.
- Lotze M. In: Cancer: Principles & Practice of Oncology. 9th ed. 2011.
- Sondak VK, Hauschild A, et al. In: Cancer: Principles & Practice of Oncology. 9th ed. 2011.
- Robinson MK, Weiner LM, et al. In: Cancer: Principles & Practice of Oncology. 9th ed. 2011.
